Conflicts of interest statement
AO and SPR are Directors of Tandem Nano Ltd. AO has received research
funding from ViiV, Merck, Janssen and consultancy from Gilead, ViiV and
Merck not related to the current paper. PON is currently engaged in a
collaboration with Romark LLC but this interaction did not influence the
prioritisation or conclusions in the current manuscript. No other
conflicts are declared by the authors.